Loading organizations...
§ Venture Capital · Los Altos, CA, USA
Nissim Capital operates as a venture capital firm, strategically deploying capital into HealthTech companies. The firm primarily focuses on Series E stage investments, targeting promising US-based startups that are typically at an advanced stage of development and poised for significant market expansion. Its investment approach emphasizes providing late-stage financing to support growth and scale within its chosen sector.
The firm was established in 2015, reflecting a concentrated investment thesis within the venture landscape. Operating with a lean structure, the firm is led by a singular partner whose expertise guides its investment decisions. This focused operational model allows for agile decision-making and a deep specialization in the HealthTech domain, driving its targeted investment strategy.
Nissim Capital's portfolio companies are innovators within the HealthTech space, benefiting from capital designed to propel them through critical expansion phases. The firm's long-term vision centers on cultivating robust growth in the HealthTech sector by backing companies with proven solutions and substantial market potential, aiming to foster lasting impact through strategic capital infusion.
Nissim Capital has 1 tracked investment across 1 company. The latest tracked deal is $100.0M Series E in Visby in February 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2022 | Visby | $100.0M Series E | Donald Lacey | Alumni Ventures, General Catalyst, Greylock, Innovation Endeavors, Kleiner Perkins, LGF, Kenneth Griffin, Artiman Ventures, Blue Water Life Science Advisors, Cedars Sinai Medical Center, Jennifer Shum, NanoDimension, Pitango Venture Capital |